John Lopiccolo
Podiatrist · Morehead City, NCNPI 1679599963
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,400 of the $3,713 with a category attached, or 64.6%. Arthrex accounts for 87.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $3,373 and has fallen 98.2% since, to $60 in 2025.
Across 33 payments — averaging $112.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Tricoast Surgical Solutions LLC$156
- Stryker$94
- Averitas Pharma Inc.$86
- Smith+Nephew$57
- GRT US Holding, Inc.$28
- plus $52 from 4 others
What the payments were for
- Travel & lodging$64717%
- Food & beverage$57215%
- Education$2,40065%
- Gifts$943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 15 | $3,240 |
| Tricoast Surgical Solutions LLC | 4 | $156 |
| Stryker | 1 | $94 |
| Averitas Pharma Inc. | 3 | $86 |
| Smith+Nephew | 4 | $57 |
| GRT US Holding, Inc. | 2 | $28 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| Nevro Corp. | 1 | $12 |
| Kerecis Limited | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $12 |
How this compares
$3,713 in reported general payments places this provider in the 70th percentile of 109 podiatrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 31 | $1,212 |
| Ketoconazole | 132 | $1,037 |
| Mupirocin | 92 | $819 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 70 | $779 |
| Ammonium Lactate | 41 | $742 |
| Doxycycline Hyclate | 40 | $387 |
| Silver Sulfadiazine | 59 | $344 |
| Diclofenac Sodium | 20 | $341 |
| Gabapentin | 56 | $319 |
| Duloxetine Hcl | 27 | $271 |
| Cephalexin | 47 | $238 |
| Terbinafine Hcl | 22 | $195 |
| Prednisone | 21 | $192 |
| Ciprofloxacin Hcl | 22 | $181 |
| SsdSilver Sulfadiazine | 14 | $169 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Morehead City
- Jordan MeyersRaleigh$343K
- Christopher GaulandGreenville$56K
- Scott MartinRocky Mount$14K
- Gretchen LawrenceForest City$12K
- William WeilyCharlotte$11K
- Kristin KirbyHuntersville$10K
- Robert PrzynoschWaynesville$9K
- William BanksWaynesville$9K
- Emily LobosAsheville$9K
- Richard LindCharlotte$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.